CLINICAL AND LABORATORY ASPECTS OF CHRONIC HEPATITIS B ON THE BACKGROUND OF REFRACTORY ANEMIA OF INFLAMMATION IN CHILDREN OF UZBEKISTAN
https://doi.org/10.22627/2072-8107-2017-16-3-24-27
Abstract
A total of 75 children with chronic hepatitis B (ChHB) with a refractory variant of anemia of inflammation (AV) course were examined, the pathogenetic manifestation of which was the development of iron overload syndrome (IOS). It was revealed that against the background of an increase in the severity of the IOS, the incidence of progressive forms of the disease with persistent prevalence of asthenovegetative, hemorrhagic syndromes and severe hepatosplenomegaly increased. At the same time, the leading biochemical syndromes were the presence of cytolysis with prolonged hyperfermentemia, endotoxemia and mesenchymal inflammatory syndrome. A directly proportional dependence of the hepcidin-25 peptide level on the degree of expression of the IOS, the higher the presentation of the IOS, the higher the level of suppression of peptide expression in hepatocytes. Diagnostically significant tests of severe forms of IOS in ChHB in children are the presence of hemosiderin in the urine and an increase in the level of sIL-6R in the serum.
About the Authors
F. I. Inoyatova
Republican specialized scientific-practical medical center pediatrics of Ministry of Health of Uzbekistan
Uzbekistan
Uzbekistan
M.D., Professor, Head of Hepatology Department
Kh. M. Kadyrkhodjaeva
Republican specialized scientific-practical medical center pediatrics of Ministry of Health of Uzbekistan
Uzbekistan
Uzbekistan
G. Z. Inogamova
Republican specialized scientific-practical medical center pediatrics of Ministry of Health of Uzbekistan
Uzbekistan
Uzbekistan
A. Kh. Akhmedova
Republican specialized scientific-practical medical center pediatrics of Ministry of Health of Uzbekistan
Uzbekistan
Uzbekistan
N. K. Valieva
Republican specialized scientific-practical medical center pediatrics of Ministry of Health of Uzbekistan
Uzbekistan
Uzbekistan
F. G. Abdullaeva
Republican specialized scientific-practical medical center pediatrics of Ministry of Health of Uzbekistan
Uzbekistan
Uzbekistan
N. A. Ikramova
Republican specialized scientific-practical medical center pediatrics of Ministry of Health of Uzbekistan
Uzbekistan
Uzbekistan
References
1. Раков А.Л., Лобзин Ю.В., Горбаков В.В. и др. Актуальные проблемы гепатологии: эпидемиология вирусных гепатитов. Прил. к Т.232. Воен. мед. журнал. М.: Воен. Изд., 2002: 996. [Rakov A.L., Lobzin Yu.V., Gorbakov V.V. and others. Actual problems of hepatology: epidemiology of viral hepatitis. Ad. to T.232. Military medical.Journal. M.: Military Ed., 2002: 996. (In Russ.)]
2. Болезни печени и желчевыводящих путей: Руководство для врачей. Под ред. В.Т.Ивашкина. 2-е изд., испр. и доп. М.: Изд. Дом «М-Вести», 2005: 536. [Diseases of the liver and biliary tract: A guide for doctors. Ed. V.T. Ivashkin. 2 nd ed., Rev. and additional. Moscow: Izd. House of «M-Vesti», 2005: 536. (In Russ.)]
3. Иноятова Ф.И. Хронический вирусный гепатит В у детей. Ташкент: Изд. «Шарк», 2009: 415. [Inoyatova F.I. Chronic viral hepatitis B in children. Tashkent: Ed. Shark, 2009: 415. (In Russ.)]
4. Кулагина Е.А., и др. Клинико-генетическое исследование синдрома перегрузки железом при хронических диффузных заболеваниях печени. БЮЛЛЕТЕНЬ СО РАМП. 2009, 3:36—41. [Kulagina EA, et al. Clinical and genetic study of iron overload syndrome in chronic diffuse liver diseases. RAMP BULLETIN. 2009, 3: 36—41. (In Russ.)]
5. Охотникова Е.Н. Анемия при хронических заболеваниях. Клиническая иммунология. Аллергология. Инфектология. 2012, 5—6:54—55. [Okhotnikova E.N. Anemia in chronic diseases. Clinical Immunology. Allergology. Infectology. 2012, 5—6: 54—55. (In Russ.)]
6. Weizer-Stern O., Adamsky K., Margalit O. et al. Hepcidin, a key regulator of iron metabolism, is transcriptionally activated by p53. Br. J. Haemotol. 2007, 2:253—262.
7. Wiess G. Iron metabolism in the anemia of chronic disease. Bio-chim. Biophis. Acta. 2008, dio:10.
8. Богуш Л.С., Сивицкая Л.Н., Даниленко Н.Г. Роль C282Y и H63D мутаций гена HFE в формировании вторичной перегрузки железом. Мед. панорама. 2009:52—55. [Bogush L.S., Sivitskaya L.N., Danilenko N.G. Role of C282Y and H63D mutations in the HFE gene in the formation of secondary iron overload. Med. panorama. 2009: 52—55. (In Russ.)]
9. Козловская Л.В., Рамеев В.В., Саркисова И.А. Патогенез и клиническое значение анемии хронических заболеваний. Анемия. 2005, 4: 4—10. [Kozlovskaya L.V., Rameev V.V., Sarkisova I.A. Pathogenesis and clinical significance of anemia of chronic diseases. Anemia. 2005, 4: 4—10. (In Russ.)]
10. Иноятова Ф.И., Абдумаджидова Ш.У., Иногамова Г.З. и др. Некоторые аспекты патогенеза и диагностики анемии воспаления у детей, больных хроническим гепатитом В. Информ. письмо. Ташкент. 2013:10. [Inoyatova F.I., Abdumadzhidova Sh.U., Inogamova G.Z. Some aspects of the pathogenesis and diagnosis of anemia of inflammation in children with chronic hepatitis B. Inform. letter. Tashkent. 2013: 10. (In Russ.)]
11. Алиева А.М., Намазова-Баранова Л.С., Казюкова Т.В., Студеникин В.М. Представления о метаболизме железа у детей в норме и при инфекционных заболеваниях. Детские инфекции. 2017, 16(1):21—27. [Alieva A.M., Namazova-Baranova L.S., Kazyukova T.V., Studenikin V.М. Representations of iron metabolism in children in normal and infectious diseases. Detskie Infektsii=Children's infections. 2017, 16 (1): 21—27. (In Russ.)]
12. Ramey G., Deschemin J.C., Durel B., et al. Hepcidin targets ferro-portin for degradation in hepatocytes. Haematologica. 2009; 95:501—4.
13. Смирнов О.А. Железо-регуляторный гормон печени гепцидин и его место в системе врожденного иммунитета. Р.Ж.Г.Г.К. 2008, 2:48—54. [Smirnov O.A. The iron-regulatory hormone of the liver is hepcidin and its place in the system of innate immunity. Russ.Jour.Gastr.Hepat.Koloproc. 2008, 2: 48—54. (In Russ.)]
14. Papnicolaou G., Trilianos M., Christakis J. et al. Hepcidin in iron overload disorders. Blood. 2005, 105:4103—4105.
15. Маянский Н.А., Семикина Е.Л. Гепсидин: основной регулятор обмена железо и новый диагностический маркер. Вопросы диагностики в педиатрии. 2009, 1:18—23. [Mayanskiy N.A., Semikina E.L. Hepsidine: the main regulator of iron metabolism and a new diagnostic marker. Diagnostic issues in pediatrics. 2009, 1: 18—23. (In Russ.)]
16. Park C., Valore E., Waring A. et al. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J.boil.Chem. 2001, 276:7806— 7810.
17. Nemeth E., Ganz T. Regulation of iron metabolism by hepcidin. Annu. Rev. Nutr. 2006; 26:323—42.
18. Nemeth E., Rivera S., Gabayan V. et al. Il 6 mediates hypoferremia in inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J.Clin. Invest. 2004; 113: 1271—1276.
19. Corradini E., Meynard D., Wu Q., et al. Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in mice. Hepatology. 2011; 54:273—84.
20. Ohgami R.S., Campagna D.R., McDonald A., et al. The Steap proteins are metalloreductases. Blood. 2006; 108:1388—94.
Review
For citations:
Inoyatova F.I., Kadyrkhodjaeva Kh.M., Inogamova G.Z., Akhmedova A.Kh., Valieva N.K., Abdullaeva F.G., Ikramova N.A. CLINICAL AND LABORATORY ASPECTS OF CHRONIC HEPATITIS B ON THE BACKGROUND OF REFRACTORY ANEMIA OF INFLAMMATION IN CHILDREN OF UZBEKISTAN. CHILDREN INFECTIONS. 2017;16(3):24-27. (In Russ.) https://doi.org/10.22627/2072-8107-2017-16-3-24-27
Views:
733
Email this article 